Picard Medical, Inc.
PMI
$0.16
-$0.01-7.58%
AMEX
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 13.97% | -15.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.97% | -15.00% | |||
| Cost of Revenue | 46.32% | -54.59% | |||
| Gross Profit | -33.09% | 416.15% | |||
| SG&A Expenses | 0.84% | 19.16% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 41.10% | -14.16% | |||
| Operating Income | -50.22% | 13.88% | |||
| Income Before Tax | -77.65% | 58.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -77.49% | 58.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -77.49% | 58.84% | |||
| EBIT | -50.22% | 13.88% | |||
| EBITDA | -50.69% | 14.02% | |||
| EPS Basic | -75.77% | 69.61% | |||
| Normalized Basic EPS | 15.78% | 62.41% | |||
| EPS Diluted | -75.77% | 69.61% | |||
| Normalized Diluted EPS | 15.78% | 62.41% | |||
| Average Basic Shares Outstanding | 1.00% | 35.35% | |||
| Average Diluted Shares Outstanding | 1.00% | 35.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||